Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04409015 · ClinicalTrials.gov registry record
ROTEM® Obstetric Hemorrhage Pilot Study
A clinical trial of High Risk Postpartum Hemorrhage (PPH), sponsored by Ohio State University.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04409015: Completed study of High Risk Postpartum Hemorrhage (PPH), sponsored by Ohio State University.
NCT04409015 is a study of High Risk Postpartum Hemorrhage (PPH) that has completed, run by Ohio State University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04409015, a study of High Risk Postpartum Hemorrhage (PPH), has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
Conditions Studied
Interventions
- DEVICE ROTEM - rotation thromboelastometry testing
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2022-03-01 |
What the finished NCT04409015 record still lists
NCT04409015 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with High Risk Postpartum Hemorrhage (PPH) appearing as the primary indexed condition, and to 1 intervention - of which ROTEM - rotation thromboelastometry testing is the first listed.
NCT04409015 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04409015 about?
NCT04409015 is a clinical study titled "ROTEM® Obstetric Hemorrhage Pilot Study". This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
What is the current status of trial NCT04409015?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-07-27. Estimated completion is 2022-03-01.
What conditions does trial NCT04409015 study?
This clinical trial studies the following conditions: High Risk Postpartum Hemorrhage (PPH).
What interventions are being tested in trial NCT04409015?
The interventions under investigation include: ROTEM - rotation thromboelastometry testing (DEVICE).
Who is sponsoring clinical trial NCT04409015?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04409015 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI